Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Multiple Myeloma t(4 ;14) FFPE Samples
BIWAKO-sponsored clinical study investigating t(4;14) FFPE samples in multiple myeloma and malignant plasma cell neoplasms; the trial is cur…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies [Phase 1]
Phase 1 study of COM902, a TIGIT inhibitor, in patients with advanced malignancies is ongoing and currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders [Phase 4]
Phase 4 trial evaluating influenza vaccination to prevent flu in patients with plasma cell neoplasms has completed and posted results.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease [Phase 1, Phase 2]
This clinical trial update covers a BCMA-targeted CAR-T cell therapy being explored for relapsed/refractory multiple myeloma and plasma cell…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease [Phase 1, Phase 2]
A BCMA-targeted Prime CAR-T cell therapy is being evaluated for relapsed/refractory multiple myeloma and plasma cell neoplasms in Phase 1/2 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies [Phase 2]
Phase 2 clinical trial update on shorter course tacrolimus after non-myeloablative conditioning with related donor PBSCT and high-dose postt…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]
Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial update for combination chemotherapy in treating patients with multiple myeloma and plasma cell neoplasm.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma [Phase 2]
Phase 2 trial updating combination chemotherapy, peripheral stem cell transplant, biological therapy, pamidronate, and thalidomide in multip…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating activated white blood cells with autologous stem cell transplant for newly diagnosed multiple myeloma co…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma [EARLY_Phase 1]
Early-phase clinical trial evaluating interferon alfa and interleukin-6 in patients with recurrent multiple myeloma; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma [NA]
Results from a completed clinical trial examining immune reconstitution after autologous hematopoietic stem cell transplantation in high-ris…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: Study of DNA Samples From Patients With Multiple Myeloma
An update on a study collecting DNA samples from patients with multiple myeloma, noting that the study status is completed.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
This update reports on a completed clinical study examining blood samples from patients with multiple myeloma and plasma cell neoplasms who …
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of ANGEL, an EBV-specific cytotoxic T-cell therapy for relapsed Epstein…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis [Phase 2]
Phase 2 trial update evaluating a second autologous stem cell transplant in patients with persistent or recurrent AL amyloidosis, with resul…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports a completed Phase 1/2 study of arsenic trioxide plus vitamin C in patients with recurrent or refractory m…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Clinical trial update on biomarkers related to thrombosis in patients with newly diagnosed multiple myeloma receiving chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of sorafenib and everolimus in relapsed or refractory lymphoma and multiple myeloma with results po…